<?xml version="1.0" encoding="UTF-8"?>
<p>Total UHEP costs, based on the calculated number of treated patients (
 <xref rid="T1" ref-type="table">Table</xref>), were estimated to be US$3,238,000, approximately one quarter of the estimated US$13,419,000 for a non-UHEP program of the same scope and size (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>). The simplified testing and cost-containment measures (e.g., pooled procurement, waived duty taxes, and negotiated markups) substantially lowered total cost. Using the catalytic funding model, only US$1,616,000 in upfront costs were required to conduct the same program, with total program costs, including the upfront catalytic investment, covered by patient payments (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>).
</p>
